Sonoma Pharmaceuticals, Inc.
SNOA
$5.09
$0.030.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.61M | 5.37M | 5.24M | 4.08M | 2.59M |
| Total Receivables | 2.83M | 2.44M | 2.61M | 3.38M | 3.48M |
| Inventory | 3.80M | 2.92M | 3.14M | 2.84M | 2.66M |
| Prepaid Expenses | 2.87M | 1.92M | 1.39M | 1.93M | 3.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.11M | 12.65M | 12.38M | 12.22M | 11.93M |
|
|
|||||
| Total Current Assets | 13.11M | 12.65M | 12.38M | 12.22M | 11.93M |
| Net Property, Plant & Equipment | 837.00K | 309.00K | 334.00K | 417.00K | 518.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 650.00K | 736.00K | 954.00K | 1.05M | 1.23M |
| Total Assets | 14.59M | 13.69M | 13.67M | 13.69M | 13.67M |
|
|
|||||
| Total Accounts Payable | 2.05M | 953.00K | 1.40M | 770.00K | 751.00K |
| Total Accrued Expenses | 1.84M | 1.74M | 1.92M | 2.02M | 2.23M |
| Short-term Debt | 139.00K | 220.00K | -- | 82.00K | 204.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 96.00K | 58.00K | 90.00K | 116.00K | 155.00K |
| Total Finance Division Other Current Liabilities | 731.00K | 1.13M | 302.00K | 319.00K | 413.00K |
| Total Other Current Liabilities | 731.00K | 1.13M | 302.00K | 319.00K | 413.00K |
| Total Current Liabilities | 4.85M | 4.10M | 3.70M | 3.31M | 3.75M |
|
|
|||||
| Total Current Liabilities | 4.85M | 4.10M | 3.70M | 3.31M | 3.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 139.00K | 220.00K | -- | 82.00K | 204.00K |
| Capital Leases | 440.00K | 27.00K | 29.00K | 46.00K | 61.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.25M | 5.16M | 5.07M | 4.98M | 4.89M |
| Total Liabilities | 10.54M | 9.28M | 8.80M | 8.33M | 8.70M |
|
|
|||||
| Common Stock & APIC | 206.67M | 206.59M | 206.45M | 205.65M | 204.07M |
| Retained Earnings | -199.05M | -197.81M | -197.03M | -196.10M | -195.49M |
| Treasury Stock & Other | -3.57M | -4.38M | -4.55M | -4.20M | -3.60M |
| Total Common Equity | 4.06M | 4.41M | 4.87M | 5.35M | 4.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.06M | 4.41M | 4.87M | 5.35M | 4.98M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.06M | 4.41M | 4.87M | 5.35M | 4.98M |
|
|
|||||